Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CC Stock Forecast 2026-2027
$17.52
Current Price
$2.78B
Market Cap
Buy 5
Hold 4
Sell 0
Wall St Analyst Ratings
Distance to CC Price Targets
+71.2%
To High Target of $30.00
+42.7%
To Median Target of $25.00
+19.9%
To Low Target of $21.00
CC Price Momentum
-1.6%
1 Week Change
-19.5%
1 Month Change
+29.2%
1 Year Change
+48.6%
Year-to-Date Change
-38.9%
From 52W High of $28.67
+67.8%
From 52W Low of $10.44
📊 TOP ANALYST CALLS
Did CC Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Chemours is one of their latest high-conviction picks.
Latest CC Stock Price Targets & Analyst Predictions
Based on our analysis of 2 Wall Street analysts, CC has a bullish consensus with a median price target of $25.00 (ranging from $21.00 to $30.00). The overall analyst rating is Strong Buy (8.0/10). Currently trading at $17.52, the median forecast implies a 42.7% upside. This outlook is supported by 5 Buy, 4 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CC Analyst Ratings
5
Buy
4
Hold
0
Sell
CC Price Target Range
Low
$21.00
Average
$25.00
High
$30.00
Current: $17.52
Latest CC Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CC.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Jul 1, 2026 | Mizuho | John Roberts | Outperform | Maintains | $25.00 |
| May 21, 2026 | JP Morgan | Neutral | Maintains | $N/A | |
| May 11, 2026 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| May 11, 2026 | RBC Capital | Outperform | Maintains | $N/A | |
| May 8, 2026 | UBS | Buy | Maintains | $N/A | |
| Apr 28, 2026 | Truist Securities | Buy | Maintains | $N/A | |
| Apr 9, 2026 | UBS | Buy | Maintains | $N/A | |
| Apr 9, 2026 | Truist Securities | Buy | Maintains | $N/A | |
| Mar 5, 2026 | Mizuho | Outperform | Maintains | $N/A | |
| Feb 25, 2026 | Goldman Sachs | Neutral | Maintains | $N/A | |
| Feb 23, 2026 | UBS | Buy | Maintains | $N/A | |
| Feb 23, 2026 | BMO Capital | Outperform | Maintains | $N/A | |
| Feb 23, 2026 | JP Morgan | Neutral | Maintains | $N/A | |
| Feb 23, 2026 | Morgan Stanley | Equal-Weight | Maintains | $N/A | |
| Jan 21, 2026 | Truist Securities | Buy | Maintains | $N/A | |
| Dec 3, 2025 | JP Morgan | Neutral | Maintains | $N/A | |
| Nov 11, 2025 | UBS | Buy | Maintains | $N/A | |
| Nov 10, 2025 | Truist Securities | Buy | Maintains | $N/A | |
| Nov 10, 2025 | RBC Capital | Outperform | Maintains | $N/A | |
| Oct 16, 2025 | Mizuho | Outperform | Maintains | $N/A |
Chemours Co. (CC) Competitors
The following stocks are similar to Chemours based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Chemours Co. (CC) Financial Data
Chemours Co. has a market capitalization of $2.78B with a P/E ratio of 67.8x. The company generates $5.82B in trailing twelve-month revenue with a -7.0% profit margin.
Revenue growth is +1.0% quarter-over-quarter, while maintaining an operating margin of +3.0% and return on equity of -103.0%.
Valuation Metrics
Market Cap
$2.78B
Enterprise Value
$6.56B
P/E Ratio
67.8x
PEG Ratio
0.1x
Price/Sales
0.5x
Growth & Margins
Revenue Growth (YoY)
+1.0%
Gross Margin
+15.4%
Operating Margin
+3.0%
Net Margin
-7.0%
EPS Growth
+1.0%
Financial Health
Cash/Price Ratio
+21.4%
Current Ratio
1.8x
Debt/Equity
2,033.8x
ROE
-103.0%
ROA
+2.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Chemours Co. (CC) Business Model
About Chemours Co.
What They Do
Provides customized industrial and specialty chemicals.
Business Model
The company operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, generating revenue by producing and supplying a range of chemical solutions for various industries. By focusing on products that enhance energy efficiency and meet environmental goals, Chemours caters to sectors such as automotive, construction, and electronics.
Additional Information
Founded in 2015 and headquartered in Wilmington, Delaware, Chemours Co. has a global presence with manufacturing facilities and research centers worldwide, primarily generating revenue from North America.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
5,700
CEO
Ms. Denise M. Dignam
Country
United States
IPO Year
2015
Website
www.chemours.comChemours Co. (CC) Latest News & Analysis
Latest News
Quick Summary
Virtune has completed the rebalancing of the Virtune Stablecoin Index ETP (SE0026821282), listed on Nasdaq Stockholm, Nasdaq Helsinki, and Xetra as of July 1, 2026.
Why It Matters
The completion of rebalancing for the Virtune Stablecoin Index ETP may affect its performance and liquidity, influencing investment strategies and market sentiment in the crypto asset space.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
Chemours (CC) experienced significant trading volume recently, but recent earnings estimate revisions may hinder its upward momentum in the near term.
Why It Matters
Increased trading volume for Chemours suggests heightened interest, but negative earnings estimate revisions could indicate potential challenges ahead, impacting stock performance.
Source: Zacks Investment Research
Market Sentiment:
Positive
Quick Summary
Chemours will pay $22.5 million in civil penalties and fund $90 million for mitigation projects over 15 years to settle federal and West Virginia environmental claims regarding PFAS emissions.
Why It Matters
Chemours' $22.5 million penalty and $90 million in mitigation projects signal increased regulatory scrutiny and potential costs, impacting profitability and future cash flows for investors.
Source: PRNewsWire
Market Sentiment:
Negative
Canton Strategic Holdings, Inc. Expected to Be Included in Russell 3000® and Russell 2000®
1 month ago
Quick Summary
Canton Strategic Holdings (NASDAQ: CNTN) is set to join the Russell 3000® and Russell 2000® indices after the June 26, 2026 reconstitution, enhancing its visibility in the market.
Why It Matters
Canton Strategic Holdings' inclusion in the Russell 3000® and Russell 2000® could boost its visibility and liquidity, attracting more institutional investors and potentially increasing its stock price.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Chemours (CC) reported earnings 30 days ago; investors may want to monitor upcoming developments and market reactions for future stock performance.
Why It Matters
Chemours' recent earnings report will influence market sentiment and stock performance, impacting investor decisions regarding growth potential and valuation.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
The rise of AI is increasing demand for liquid cooling technologies to manage heat in data centers, presenting new investment opportunities beyond semiconductors and cloud computing.
Why It Matters
The rise of AI boosts demand for liquid cooling technologies, presenting new investment opportunities as firms adapt to increased energy needs and server heat, shifting focus from traditional sectors.
Source: Invezz
Market Sentiment:
Positive
Frequently Asked Questions About CC Stock
What is Chemours Co.'s (CC) stock forecast for 2027?
Based on our analysis of 2 Wall Street analysts, Chemours Co. (CC) has a median price target of $25.00. The highest price target is $30.00 and the lowest is $21.00.
Is CC stock a good investment in 2027?
According to current analyst ratings, CC has 5 Buy ratings, 4 Hold ratings, and 0 Sell ratings. The stock is currently trading at $17.52. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CC stock?
Wall Street analysts predict CC stock could reach $25.00 in the next 12 months. This represents a 42.7% increase from the current price of $17.52. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Chemours Co.'s business model?
The company operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials, generating revenue by producing and supplying a range of chemical solutions for various industries. By focusing on products that enhance energy efficiency and meet environmental goals, Chemours caters to sectors such as automotive, construction, and electronics.
What is the highest forecasted price for CC Chemours Co.?
The highest price target for CC is $30.00 from at , which represents a 71.2% increase from the current price of $17.52.
What is the lowest forecasted price for CC Chemours Co.?
The lowest price target for CC is $21.00 from at , which represents a 19.9% increase from the current price of $17.52.
What is the overall CC consensus from analysts for Chemours Co.?
The overall analyst consensus for CC is bullish. Out of 2 Wall Street analysts, 5 rate it as Buy, 4 as Hold, and 0 as Sell, with a median price target of $25.00.
How accurate are CC stock price projections?
Stock price projections, including those for Chemours Co., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: July 18, 2026 2:14 AM UTC